CVI Holdings’s Onconova Therapeutics, Inc. Warrants ONTXW Stock Holding History

CVI Holdings’s Portfolio ONTXW Stock Details ONTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-132,227	Closed	-$3K	–	57
2019 Q3	$3K	Hold	132,227	–	–	0.01%	35
2019 Q2	$24K	Hold	132,227	–	–	0.03%	49
2019 Q1	$7K	Hold	132,227	–	–	0.01%	50
2018 Q4	$5K	Sell	132,227 -37,773	-22%	-$3.21K	0.01%	34
2018 Q3	$17K	Sell	170,000 -3,112	-2%	-$498	0.03%	38
2018 Q2	$2K	Hold	173,112	–	–	﹤0.01%	49
2018 Q1	$52K	Buy	+173,112	New	+$64.9K	0.07%	37

Other funds holding ONTXW

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CVI Holdings's ONTXW Position: Q4 2019 in Review

CVI Holdings sold out of Onconova Therapeutics, Inc. Warrants (ONTXW) in Q4 2019, closing a stake of 132,227 shares — an estimated $3K sold.

CVI Holdings first reported a position in ONTXW in Q1 2018 and held it in 7 quarters. The position peaked at $52K in Q1 2018. 3 funds tracked by Wall St. Rank hold ONTXW as of Q4 2019.

CVI Holdings reported no remaining Onconova Therapeutics, Inc. Warrants position as of Q4 2019 after selling out during the quarter.
CVI Holdings sold 132,227 Onconova Therapeutics, Inc. Warrants shares in Q4 2019, an estimated $3K.
CVI Holdings first reported a position in Onconova Therapeutics, Inc. Warrants in Q1 2018 and held it in 7 quarters.
CVI Holdings's Onconova Therapeutics, Inc. Warrants position peaked at $52K in Q1 2018.
3 funds tracked by Wall St. Rank held Onconova Therapeutics, Inc. Warrants as of Q4 2019.

Based on CVI Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.